Anteris Technologies Global Corp. logo
AVR
Health Care Equipment & Services

Anteris Technologies Global

Short interest
1.97%
+1.97 pp 30d
as of 20 Aug 2026
Reported shorts
298.2K
Shares on issue
15.127M

Anteris Technologies Global (AVR) financials

Results, ratios and statements

Latest result

Year to 31 Dec 2025 (FY25) vs FY24, figures in USD, the reporting currency

Revenue
1.9M (source: ASX (Markit))vs 2.7M (source: ASX (Markit)) (FY24)
ASX (Markit), as at 14 Oct 2026
NPAT
−94.1M (source: ASX (Markit))vs −76.3M (source: ASX (Markit)) (FY24)
ASX (Markit), as at 14 Oct 2026
EPS (basic)
n/avs n/a (FY24)
Rev YoY
−29.2%FY
EPS YoY
n/aFY
  • ASX (Markit)

Key ratios

Year to 31 Dec 2025 (FY); no balance sheet aligned with this period; prices to 14 Oct 2026

Gross margin
n/a
Operating margin
n/a
Net margin
−4,921.3%
FCF margin
n/a
ROE
n/a
ROA
n/a
FCF conversion
n/a
Net debt (excl. leases)
n/a
Net debt / EBITDA
n/a
Current ratio
n/a
Interest cover
n/a
Cash dividends paid / net profit
n/a
Market cap
n/a (no share count we can vouch for)
P/E
n/a (reports in USD)
P/B
n/a (no share count we can vouch for)

Ratios use the reporting currency (USD); market cap is in AUD. Sources: Yahoo Finance and ASX (Markit), as at 14 Oct 2026.

Financial statements

Figures in USD, the reporting currency; Yahoo Finance unless marked

AVR income, newest period first, figures in USD
Line itemFY25FY24FY23FY22
Revenue1.9M (source: ASX (Markit))2.7M (source: ASX (Markit))2.7M (source: ASX (Markit))3.2M (source: ASX (Markit))
NPAT−94.1M (source: ASX (Markit))−76.3M (source: ASX (Markit))−46.0M (source: ASX (Markit))−30.6M (source: ASX (Markit))
Shares41.6M35.9M17.8M13.9M
  • ASX (Markit)